Administrative arbeidsområder
Avtaler om forskningssamarbeid Cristin EU Finansiering Forskningskvalitet Forskningssamarbeid Forskningsstrategi
Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Ånensen, Nina
; Hjelle, Sigrun Margrethe; Van, Belle Werner; Haaland, Ingvild; Silden, Elisabeth; Bourdon, Jean-Christophe; Hovland, Randi; Tasken, Kjetil; Knappskog, Stian; Lønning, Per Eystein; Bruserud, Øystein; Gjertsen, Bjørn Tore
(2012).
Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.
Oncogene.
Vol. 31.
https://doi.org/10.1038/onc.2011.348
Øyan, Anne Margrete;
Ånensen, Nina
; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore
(2009).
Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.
BMC Cancer.
Vol. 9.
https://doi.org/10.1186/1471-2407-9-77
Ånensen, Nina
; Øyan, Anne Margrete; Huseby, Sjur; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore
(2007).
Early gene expression of acute myeloid leukemia in response to chemotherapy.
Expert Review of Anticancer Therapy.
Vol. 7.
https://doi.org/10.1586/14737140.7.5.741
Gjertsen, Bjørn Tore; Bredholt, Therese;
Ånensen, Nina
; Vintermyr, Olav
(2007).
Bcl-2 antisense in the treatment of human malignancies: A delusion in targeted therapy.
Current Pharmaceutical Biotechnology.
Vol. 8.
https://doi.org/10.2174/138920107783018381
Irish, Jonathan C.;
Ånensen, Nina
; Hovland, Randi; Skavland, Jørn; Børresen-Dale, Anne-Lise; Bruserud, Øystein; Nolan, Gary P; Gjertsen, Bjørn Tore
(2007).
Flt3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
Blood.
Vol. 109.
https://doi.org/10.1182/blood-2006-02-004234
Ersvær, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet Martin; Olsnes, Astrid Marta;
Ånensen, Nina
; Tan, Eng M.; Gjertsen, Bjørn Tore; Bruserud, Øystein
(2007).
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.
16 s.
European Journal of Haematology.
Vol. 79.
https://doi.org/10.1111/j.1600-0609.2007.00899.x
Ånensen, Nina
; Haaland, Ingvild; D Santos, Clive; Belle, Werner Van; Gjertsen, Bjørn Tore
(2006).
Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.
Current Pharmaceutical Biotechnology.
Vol. 7.
https://doi.org/10.2174/138920106777549731
Bruserud, Øystein; Stapnes, Camilla I; Tronstad, Karl Johan;
Ryningen, Anita
;
Ånensen, Nina
; Gjertsen, Bjørn Tore
(2006).
Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.
Expert opinion on therapeutic targets.
Vol. 10.
https://doi.org/10.1517/14728222.10.1.51
Ånensen, Nina
; Øyan, Anne Margrete; Bourdon, Jean-Christophe; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore
(2006).
A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia.
8 s.
Clinical Cancer Research.
Vol. 12.
https://doi.org/10.1158/1078-0432.CCR-05-1970
Van Belle, Werner; Sjøholt, Gry;
Ånensen, Nina
; Høgda, Kjell-Arild; Gjertsen, Bjørn Tore
(2006).
Adaptive contrast enhancement of two-dimensional electrophoretic protein gel images facilitates visualization, orientation and alignment.
Electrophoresis.
Vol. 27.
https://doi.org/10.1002/elps.200500925